PH16240A - Process for making histamine antagonist - Google Patents

Process for making histamine antagonist

Info

Publication number
PH16240A
PH16240A PH22351A PH22351A PH16240A PH 16240 A PH16240 A PH 16240A PH 22351 A PH22351 A PH 22351A PH 22351 A PH22351 A PH 22351A PH 16240 A PH16240 A PH 16240A
Authority
PH
Philippines
Prior art keywords
making
histamine antagonist
histamine
antagonist
making histamine
Prior art date
Application number
PH22351A
Other languages
English (en)
Inventor
Thomas Henry Brown
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PH16240A publication Critical patent/PH16240A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
PH22351A 1978-04-11 1979-04-04 Process for making histamine antagonist PH16240A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1404978 1978-04-11

Publications (1)

Publication Number Publication Date
PH16240A true PH16240A (en) 1983-08-11

Family

ID=10034068

Family Applications (2)

Application Number Title Priority Date Filing Date
PH22351A PH16240A (en) 1978-04-11 1979-04-04 Process for making histamine antagonist
PH24208A PH16841A (en) 1978-04-11 1980-06-27 Process for making histamine antagonists

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH24208A PH16841A (en) 1978-04-11 1980-06-27 Process for making histamine antagonists

Country Status (31)

Country Link
US (1) US4523015A (da)
EP (1) EP0004793B1 (da)
JP (1) JPS54138580A (da)
KR (1) KR820002136B1 (da)
AT (1) AT372956B (da)
AU (1) AU527202B2 (da)
CA (1) CA1138453A (da)
CS (1) CS210684B2 (da)
CY (1) CY1194A (da)
DD (1) DD142878A5 (da)
DE (1) DE2961652D1 (da)
DK (1) DK147379A (da)
ES (1) ES479469A1 (da)
FI (1) FI791143A (da)
GR (1) GR66986B (da)
HU (1) HU180081B (da)
IE (1) IE48080B1 (da)
IL (1) IL57005A (da)
IT (1) IT1118476B (da)
KE (1) KE3284A (da)
MX (1) MX5898E (da)
MY (1) MY8500703A (da)
NO (1) NO791225L (da)
NZ (1) NZ190122A (da)
PH (2) PH16240A (da)
PL (2) PL118404B1 (da)
PT (1) PT69464A (da)
RO (1) RO76810A (da)
SU (2) SU944504A3 (da)
YU (1) YU84179A (da)
ZA (1) ZA791616B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (da) * 1978-02-13 1983-03-05 Smith Kline French Lab
CA1140129A (en) * 1979-08-21 1983-01-25 Ronald J. King 4-pyrimidone derivatives
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
ZA823149B (en) * 1981-05-27 1983-03-30 Smithkline Beckman Corp Chemical process
PT74865B (en) * 1981-05-27 1983-12-07 Smithkline Beckman Corp Process of preparing a 2-(pyridylbutylamino)-pyrimidone and of its pharmaceutically acceptable salts
DK230482A (da) * 1981-05-30 1982-12-01 Smith Kline French Lab Pyrimidonsalt og fremstilling heraf
US4772704A (en) * 1983-09-21 1988-09-20 Bristol-Myers Company 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
DE3532880A1 (de) * 1985-09-14 1987-03-26 Basf Ag 1,4-disubstituierte pyrazolderivate
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
CN107698501A (zh) * 2017-10-25 2018-02-16 遵义医学院 5,6‑二甲基‑2‑羟基烟酸的制备工艺
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787372A (fr) * 1971-08-09 1973-02-09 Ici Ltd 2-nitroamino-6-hydroxy-4-methylpyrimidines substituees en position 5
GB1383676A (en) * 1972-07-14 1974-02-12 Ici Ltd Process for making diethylamino pyrimidine derivatives
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
IN146736B (da) * 1975-10-02 1979-08-25 Smith Kline French Lab
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
US4216318A (en) * 1975-12-29 1980-08-05 Smith Kline & French Laboratories Limited Heterocyclic alkyl 4-pyrimidones
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
US4227000A (en) * 1978-04-11 1980-10-07 Smith Kline & French Laboratories Limited Intermediates in the process for making histamine antagonists
PT69886A (en) * 1978-07-15 1979-08-01 Smith Kline French Lab Process for preparing isoureas and isothioureas

Also Published As

Publication number Publication date
YU84179A (en) 1983-04-30
IE48080B1 (en) 1984-09-19
PL118404B1 (en) 1981-10-31
CY1194A (en) 1983-12-31
ZA791616B (en) 1980-04-30
HU180081B (en) 1983-01-28
RO76810A (ro) 1981-05-30
KE3284A (en) 1983-05-13
JPS54138580A (en) 1979-10-27
PL117998B1 (en) 1981-09-30
SU944504A3 (ru) 1982-07-15
PT69464A (en) 1979-05-01
SU906376A3 (ru) 1982-02-15
ES479469A1 (es) 1979-07-16
AU4571479A (en) 1979-10-18
IL57005A (en) 1983-11-30
DK147379A (da) 1979-10-12
NZ190122A (en) 1982-03-09
DD142878A5 (de) 1980-07-16
IE790364L (en) 1979-10-11
NO791225L (no) 1979-10-12
EP0004793A2 (en) 1979-10-17
MY8500703A (en) 1985-12-31
EP0004793A3 (en) 1979-11-28
US4523015A (en) 1985-06-11
MX5898E (es) 1984-08-22
FI791143A (fi) 1979-10-12
CS210684B2 (en) 1982-01-29
PH16841A (en) 1984-03-15
AT372956B (de) 1983-12-12
CA1138453A (en) 1982-12-28
IT1118476B (it) 1986-03-03
AU527202B2 (en) 1983-02-24
KR820002136B1 (ko) 1982-11-15
PL214792A1 (da) 1980-03-24
DE2961652D1 (en) 1982-02-18
GR66986B (da) 1981-05-15
ATA267079A (de) 1983-04-15
EP0004793B1 (en) 1981-12-30
IT7967751A0 (it) 1979-04-09

Similar Documents

Publication Publication Date Title
YU43532B (en) Process for obtaining carboxyalkyldipeptides derivatives
YU98081A (en) Process for obtaining imidosulfamide derivatives
PT70850A (en) Process for preparing histamine antagonists
YU105183A (en) Process for obtaining 2-guanidino-4-heteroarylthiazoles
PH16240A (en) Process for making histamine antagonist
PH19618A (en) Process for preparing -2-pyrrolidone
YU271582A (en) Process for obtaining new flavanes
GB2038313B (en) Process for preparing h-receptor antagonist cimetidine
YU80179A (en) Process for obtaining lysergol derivatives
PT70441A (en) Process for preparing new histamine h2-antagonists
YU42877B (en) Process for obtaining new imidazolyl pyridines
YU241279A (en) Process for obtaining 2-chlorosulfinyl-azetidine-4-one
YU198879A (en) New process for obtaining benzothiazyl-disulfide
YU42653B (en) Process for obtaining n-benzylhaloacetamide derivatives
GB2021746B (en) Machine for making ice-cubes
YU81181A (en) Process for obtaining substituted derivatives
YU112279A (en) Process for obtaining substituted dibenzylethers
YU73579A (en) Process for obtaining steroid-spiro-oxazolidinone derivatives
GB2029473B (en) Process for improving qualities
YU86879A (en) Process for obtaining 17-beta-carboxy-5-androstane-3-one
YU219379A (en) Process for obtaining new 1-benzoyl-3-thiosemicarbazide
YU252981A (en) Process for obtaining 11-dodecene-1-yl derivatives
YU304478A (en) Process for obtaining chloro-acetanilides
YU258179A (en) New process for obtaining benzothiazole-sulfenamide
YU105179A (en) Process for obtaining new deoxyanthracyclins